Skip to main content
Fig. 1 | BMC Health Services Research

Fig. 1

From: Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS)

Fig. 1

Overview of ENCOMPASS Stepped-Wedge Trial Design and Timeline. The ENCOMPASS trial design is depicted. Each study hospital begins in the Usual Care condition. Every 4 months, one study hospital transitions from Usual Care to the Sepsis Transition and Recovery (STAR) Program for the remainder of the trial. The sequence and timing of the transition for each hospital is randomly assigned. The total ENCOMPASS trial enrollment interval is 36 months. Implementation is evaluated before, during, and after the patient enrollment interval

Back to article page